1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 4th November 2024 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

Prospective Biomarkers from Plasma Metabolomics of ME/CFS Implicate Redox Imbalance in Disease Symptomatology, 2018, Hanson et al

Discussion in 'ME/CFS research' started by John Mac, Dec 6, 2018.

Tags:
  1. John Mac

    John Mac Senior Member (Voting Rights)

    Messages:
    1,006
    https://www.mdpi.com/2218-1989/8/4/90
     
    John Mac, Dec 6, 2018
    #1
    WillowJ, leokitten, Binkie4 and 21 others like this.
  2. Hoopoe

    Hoopoe Senior Member (Voting Rights)

    Messages:
    5,426
    Such consistency is rare in ME/CFS studies. Encouraging.

    I also like how this study talks about "victims of ME/CFS" and "Its constellation of symptoms has silently ruined the lives of millions of people around the world."
     
    Hoopoe, Dec 6, 2018
    #2
    It's M.E. Linda, rvallee, Sunshine3 and 22 others like this.
  3. Sunshine3

    Sunshine3 Senior Member (Voting Rights)

    Messages:
    622
    There will be no mistakes in Maureen's work, she is as thorough as they come imo.

    If M.E is a metabolic disease, are there any other metabolic diseases caused by a perturbed immune system whose treatments might benefit us? Again, I hope my question makes sense?@Jonathan Edwards @alex3619 or anyone else!!
     
    Sunshine3, Dec 6, 2018
    #3
    It's M.E. Linda, andypants, Binkie4 and 3 others like this.
  4. Hutan

    Hutan Moderator Staff Member

    Messages:
    29,377
    Location:
    Aotearoa New Zealand
    The authors seem happy that the results of their work are consistent with the results from previous ME/CFS metabolomic studies. So that's good.

    But the differences between patients and controls in the nine molecules that they have picked out from their very large survey (more than 800 molecules) look depressingly small to me. There's such a lot of overlap in the ranges.

    Screen Shot 2018-12-07 at 11.11.24 AM.png

    Is it possible that the variability in a single patients' metabolomics over time is so great that differences between patients and controls are going to be largely obscured? Do the patients actually need to be experiencing PEM in order to show clear differences?

    Maybe we need metabolomics analyses done for these nine molecules on a set of patients every day for a month, with the first half of the month spent resting and the second half of the month spent being as active as possible, with the results correlated with symptoms.
     
    Hutan, Dec 6, 2018
    #4
    Sly Saint, WillowJ, leokitten and 15 others like this.
  5. Joel

    Joel Senior Member (Voting Rights)

    Messages:
    941
    Location:
    UK
    Not a criticism (the study is what it is) but we need much bigger numbers of study participants before we know if there is anything significant here or not.
     
    Joel, Dec 6, 2018
    #5
    WillowJ, andypants, Simon M and 6 others like this.
  6. Amw66

    Amw66 Senior Member (Voting Rights)

    Messages:
    6,769
    I am probably being incredibly stupid, not having much biochemistry, but to me small differences are not the issue. Given the common nature of expression , surely in a system s condition it is not the individual difference s, but the cumulative effect of them that is as important?

    How do these differences affect rate limited processes/ signalling when combined.
    What is their impact on reactions downstream ?
     
    Amw66, Dec 6, 2018
    #6
    andypants, ladycatlover and obeat like this.
  7. Amw66

    Amw66 Senior Member (Voting Rights)

    Messages:
    6,769
    Would low blood volume impact the functional capabilities of any of these small differences?
     
    Amw66, Dec 6, 2018
    #7
    andypants likes this.
  8. alex3619

    alex3619 Senior Member (Voting Rights)

    Messages:
    2,200
    Usually.
     
    alex3619, Dec 6, 2018
    #8
    andypants, obeat and Amw66 like this.
  9. alex3619

    alex3619 Senior Member (Voting Rights)

    Messages:
    2,200
    Probably.
     
    alex3619, Dec 6, 2018
    #9
    andypants, obeat and Amw66 like this.
  10. dreampop

    dreampop Senior Member (Voting Rights)

    Messages:
    444
    dreampop, Dec 7, 2018
    #10
    Amw66 and obeat like this.
  11. Trish

    Trish Moderator Staff Member

    Messages:
    55,414
    Location:
    UK
    That was my feeling too. It doesn't seem realistic to talk of these metabolites as biomarkers when there is so much overlap with healthy controls, unless perhaps the pattern of all 9 metabolites taken together can clearly discriminate between groups. I would imagine that a next step would be to do a focused test of the 9 metabolites in much much bigger samples of pwME and healthy controls and people with other chronic health conditions.

    Perhaps, rather than trying to call these potential biomarkers, it might be more useful to look closely at the biochemical pathways they are involved in and combine it with the genetic indications coming from other studies to try to home in on what exactly is going wrong so drugs can be targeted for treatments. I'm hoping some very clever biochemists are looking into this.
     
    Trish, Dec 7, 2018
    #11
    WillowJ, leokitten, andypants and 7 others like this.
  12. NelliePledge

    NelliePledge Moderator Staff Member

    Messages:
    14,851
    Location:
    UK West Midlands
    Noddy question about Biomarkers - based on metabolites is there actually going to be something that always distinguishes correctly between people that have ME and those who don’t. If it is something everyone should have in their blood isnt it likely there will be an overlap.
     
    Last edited: Dec 7, 2018
    NelliePledge, Dec 7, 2018
    #12
    ladycatlover and Trish like this.
  13. Snow Leopard

    Snow Leopard Senior Member (Voting Rights)

    Messages:
    3,860
    Location:
    Australia
    AUC of ~0.75 is interesting, but quite poor as far as biomarkers go. On the other hand, I'm glad they did this analysis - it should be mandatory for anyone doing a study on prospective biomarkers.
     
    Snow Leopard, Dec 7, 2018
    #13
    WillowJ, Milo, Simon M and 1 other person like this.
  14. Mithriel

    Mithriel Senior Member (Voting Rights)

    Messages:
    2,816
    I think with a lot of diseases there is a pattern of things wrong before they home in on a biomarker or diagnostic test. Even when I was pregnant in 1976, an elderly doctor said to me that if a woman thought she was pregnant there was a good chance she was. 20 years ago MS was diagnosed by a pattern of responses and symptoms and migraine still has no test.

    Though I agree that the real value of these results is that they are a map to what is going wrong for us at a basic level.
     
    Mithriel, Dec 7, 2018
    #14
    Milo and ladycatlover like this.
  15. obeat

    obeat Senior Member (Voting Rights)

    Messages:
    698
    If you wanted to convince a medical sceptic, which metabolomics paper would you use?
     
    obeat, Dec 7, 2018
    #15
  16. Andy

    Andy Committee Member

    Messages:
    23,034
    Location:
    Hampshire, UK
    Andy, Feb 2, 2019
    #16
    Mij and andypants like this.

Share This Page